SiSaf is an RNA delivery and therapeutics company. Its proprietary Bio-Courier® technology addresses the limitations of other RNA delivery technologies through the hybridization of organic materials with inorganic bioabsorbable silicon.The company’s Bio-Courier portfolio includes silicon stabilized hybrid lipid nanoparticles (sshLNP) that improvethe stability, safety, and transfection efficiency of RNA. SiSaf uses sshLNP to develop a pipeline of RNA therapeutics for rare genetic disorders and is maximizing the potential of its technology through research partnerships.Led by founder and leading biomaterials specialist Dr Suzanne Saffie-Siebert, SiSaf is a venture capital backed private company. Headquartered in Guildford, UK, it has fully integrated research labs and bio-analytical facilities, a scalable technology to fast-track development, and a growing patent estate with extensive freedom to operate.

Biotechnology

Health Care

Pharmaceutical

SiSaf Ltd

Dr Suzanne Saffie-Siebert

Nissim Torabi-Pour

Nichola Kinnear

John Stanton

Charles Weatherstone

The Leadership Team at SiSaf Ltd is responsible for setting the strategic direction of the company, overseeing its operations, and ensuring alignment across various functions. Comprising key executives, including the Chairwoman & CEO, Chief Marketing Officer, Chief Technical Officer, and Chief Financial Officer, this team drives innovation in RNA delivery technologies, fosters partnerships, manages financial health, and promotes the company's mission in developing therapeutics for rare genetic disorders. Their combined expertise guides SiSaf's efforts to maximize the potential of its proprietary Bio-Courier® technology and advance the company's research and development goals.

Leadership Team

The Operations Team at SiSaf Ltd is responsible for ensuring the smooth functioning of manufacturing and supply processes related to the production of RNA therapeutics. This team manages logistics, oversees compliance with environmental health and safety standards, and handles financial operations to support business activities. By coordinating resources and optimizing processes, they play a critical role in driving efficiency and supporting the company's innovative initiatives in RNA delivery technology.

Operations Team

The Research and Development team at SiSaf Ltd focuses on advancing the application of its proprietary Bio-Courier® technology to enhance RNA delivery systems, particularly through the formulation of silicon-stabilized hybrid lipid nanoparticles (sshLNP). Comprising experts in formulation science and molecular biology, the team conducts extensive research to develop innovative RNA therapeutics aimed at treating rare genetic disorders, ensuring improvements in stability, safety, and transfection efficiency while collaborating with research partners to maximize the potential of their cutting-edge technology.

SiSaf Ltd

Org chart

Teams

Leadership Team

Operations Team

Research and Development

Offices

SiSaf Ltd

Org chart

Teams

Leadership Team

Operations Team

Research and Development

Offices

Related companies